Menu

Pharma News

Also noted on pharma: 6 April 2012

Home/Pharma News | Posted 06/04/2012

MPs concerned over medicines shortages in UK
Nineteen UK Ministers of Parliament (MP) have now signed a Parliamentary motion demanding that the government holds ‘urgent discussions’ on the selling of UK medicines abroad, which according to many is only serving to exacerbate the current drug shortage situation in the UK.

Source: Chemist & Druggist

picture57

Canada drug shortages

Home/Pharma News | Posted 30/03/2012

Sandoz, the generics unit of pharma giant Novartis, is at the centre of Canadian drug shortages, however, the company is assuring Canadians that it will not raise prices of drugs sourced from overseas.

Top 10 most read GaBI Online articles in 2011

Home/Pharma News | Posted 30/03/2012

2011 was a busy year and biosimilars was the hot topic of the year for GaBI Online.

GaBIJ 2012-1 cover

GaBI launches GaBI Journal

Home/Pharma News | Posted 01/03/2012

- A new information source for generics and biosimilars -

picture42

Canada’s generics and brand-name pharma come together to tackle drug shortages

Home/Pharma News | Posted 16/03/2012

Canada’s Research-Based Pharmaceutical Companies (Rx&D) and the Canadian Generic Pharmaceutical Association (CGPA) announced on 12 March 2012 their commitment and financial support in responding urgently to prescription drug shortages.

picture21

Greece drug shortages

Home/Pharma News | Posted 02/03/2012

A severe drug shortage is threatening to undermine the health and welfare of Greek citizens as prescription drugs and even basic over-the-counter medicines are in increasingly short supply. Even finding common drugs such as Aspirin has become a major problem in Greece.

picture12

Score lines won’t delay generics

Home/Pharma News | Posted 24/02/2012

In an attempt to delay generics competition, Irish pharma company Warner Chilcott had added a second line or score to its Doryx (doxycycline hyclate) tablet. On 8 February 2012, FDA however denied the company’s citizen petition demanding that generic versions should also have the two score lines.

picture47

UK drug shortages are far from being solved

Home/Pharma News | Posted 13/01/2012

Despite attempts to solve problems with shortages of brand-name medicines in the UK, the issue is taking up more of pharmacists’ time, is far from being solved and may be getting worse according to an online stock survey carried out by pharmacists organisation Chemist+Druggist.

picture 77

Drug shortage woes continue in the UK

Home/Pharma News | Posted 27/01/2012

Despite attempts to solve problems with shortages of brand-name medicines in the UK, the issue is far from beings resolved. The latest news is that the UK’s wholesalers have called for a ‘third-party monitoring and survey service’ to help tackle medicines shortages, while the Association of the British Pharmaceutical Industry (ABPI) is calling for sanctions on pharmacists that act as wholesalers.

picture 72

Shortages of ADHD drugs expected during 2012

Home/Pharma News | Posted 20/01/2012

Drugs used to treat attention deficit hyperactivity disorder (ADHD) are in such short supply that FDA has reported that it receives hundreds of complaints from patients unable to fill their prescriptions.

picture59

UK drug shortages continue to affect pharmacists and patients

Home/Pharma News | Posted 16/12/2011

Shortages of brand-name medicines are as much of a problem in 2011 as they were in 2010, according to a survey by the Pharmaceutical Services Negotiating Committee (PSNC).

picture49

Hospira’s manufacturing troubles may add to drug shortages

Home/Pharma News | Posted 09/12/2011

Injectable generics specialist, Hospira, is under scrutiny again regarding drug shortages caused by its continuing lack of compliance with FDA requirements. In fact, one analyst from The Wall Street believes that the company has production problems that require long-term attention and that could lead to it receiving a consent decree from FDA.

picture27

Biosimilars and cancer drug shortages in Europe

Home/Pharma News | Posted 18/11/2011

With all the talk about drug shortages in the US it might be easy to forget the rest of the world, but it seems that drug shortages are also hitting European countries and are affecting not just generics, but also biosimilars.

picture34

Members of parliament to hold inquiry into UK drug shortages

Home/Pharma News | Posted 25/11/2011

On 21 November 2011, a group of UK members of parliament (MPs) announced that they will hold a full-scale inquiry into the continuing problem of drug shortages within the National Health Service (NHS).

picture18

Some relief from drug shortages in the US

Home/Pharma News | Posted 10/11/2011

There finally appears to be some light at the end of the tunnel, with one of the main victims of shortages—the sterile injectable drug propofol—finally being declared no longer in short supply by FDA.

picture09

Obama’s fresh attempts to ease drugs shortages in the US

Home/Pharma News | Posted 04/11/2011

Action by the President
President Barack Obama signed an executive order 31 October 2011 to address an escalating shortage of life-saving medicines, his newest effort to advance social and economic measures that have stalled in Congress.

picture16

Cancer drug shortages in the US

Home/Pharma News | Posted 10/11/2011

There is concern being expressed about the growing number of drug shortages among essential and lifesaving cancer drugs.

picture11

Sun Pharma offers to buy remaining Taro shares

Home/Pharma News | Posted 10/11/2011

Taro Pharmaceutical Industries confirmed that it had received a letter on 19 October 2011 from Sun Pharma offering to buy all outstanding shares of Taro, not currently held by Sun Pharma, at a price of US$24.50 per share.

picture 92

Pfizer invests Euros 145 million in Irish biotech site

Home/Pharma News | Posted 28/10/2011

Pfizer, the world’s leading pharmaceutical company, is to make a substantial investment of Euros 145 million at its Grange Castle biotechnology manufacturing facility in Clondalkin, Dublin, Ireland, it was revealed 22 September 2011.

picture 93

Drawing score lines on pills to delay generics

Home/Pharma News | Posted 28/10/2011

Brand-name drugmakers have come up with numerous ways in the past to delay generics from entering the market. These can include making slight changes to the doses, introducing a paediatric form, pay-for-delay deals or even buying the company that makes the active pharmaceutical ingredient. The latest novel tactic from an originator drug company, however, is coming simply in the form of a line.